|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SCYX | Angulo Gonzalez David | Chief Executive Officer | Sep 12 '24 | Buy | 1.37 | 20,000 | 27,400 | 507,871 | Sep 16 08:00 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Dec 21 '20 | Buy | 6.25 | 1,600 | 10,000 | 23,780 | Dec 23 09:00 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Dec 31 '18 | Buy | 0.50 | 12,000 | 5,951 | 121,790 | Jan 02 11:28 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Sep 06 '18 | Buy | 1.27 | 7,000 | 8,890 | 108,790 | Sep 10 09:09 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Mar 29 '18 | Buy | 1.36 | 6,000 | 8,160 | 101,790 | Apr 02 08:10 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Mar 08 '18 | Buy | 1.39 | 7,000 | 9,730 | 95,790 | Mar 12 04:43 PM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Mar 08 '18 | Buy | 1.69 | 14,790 | 24,995 | 88,790 | Mar 12 08:48 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Aug 11 '17 | Buy | 1.55 | 10,000 | 15,500 | 72,000 | Aug 14 04:29 PM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | May 12 '17 | Buy | 1.70 | 15,000 | 25,500 | 62,000 | May 15 08:17 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Dec 16 '16 | Buy | 3.25 | 4,000 | 13,000 | 46,000 | Dec 19 06:44 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Jun 29 '16 | Buy | 2.18 | 4,800 | 10,464 | 8,850 | Jul 01 10:31 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Jun 30 '16 | Buy | 2.23 | 32,150 | 71,694 | 41,000 | Jul 01 10:31 AM |
SCYX | Angulo Gonzalez David | Chief Medical Officer | Sep 15 '15 | Buy | 7.00 | 3,000 | 21,000 | 3,000 | Sep 18 04:59 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite